Monitoring immune responses after glioma vaccine immunotherapy
/in Glioblastoma, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):195-9Heat shock proteins in glioblastomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):111-23Clinical applications of a peptide-based vaccine for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-01-01 / Neurosurg. Clin. N. Am. 2010 Jan;21(1):95-109Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results
/in Glioblastoma, Hyperthermia, International Publications /von 2009-12-24 / J. Neurooncol. 2010 Jul;98(3):395-405Heat-shock protein vaccines as active immunotherapy against human gliomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2009-10-27 / J. Immunol. Methods 2010 Jan;352(1-2):169-73An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
/in Glioblastoma, International Publications /von 2009-10-01 / Mol. Cancer Ther. 2009 Oct;8(10):2773-9Immunotherapy of diffuse gliomas: biological background, current status and future developments
/in Glioblastoma, International Publications /von 2009-10-01 / Brain Pathol. 2009 Oct;19(4):674-93Dendritic cell therapy of high-grade gliomas
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2009-10-01 / Brain Pathol. 2009 Oct;19(4):694-712
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de